SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: biostruggle who wrote (1664)2/13/2002 5:26:20 PM
From: Robohogs  Respond to of 10345
 
I would try MRK, JNJ, SGP (value play with issues as is MRK), or AZN or PFE then. PFE is the class of the world, AZN is interesting, JNJ is just flat solid and MRK and SGP could be cheap.

Jon



To: biostruggle who wrote (1664)2/13/2002 9:50:15 PM
From: Hector  Read Replies (2) | Respond to of 10345
 
Marvin,

Isn't 18-20 about 40-50% upside potential from the current price?

Seems like a pretty good speculation to me on a pretty decent little pharmaceutical company.

BTW, did you ever notice how the bond rating agencies and stock analysts have a habit of downgrading these issues only after they've already lost a good chunk of their value?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News